Cited by 73Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology

Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play

Open access
Manduca, Antonia, Lassalle, Olivier, Sepers, Marja, Campolongo, Patrizia, Cuomo, Vincenzo, Marsicano, Giovanni, Kieffer, Brigitte, Vanderschuren, Louk J. M. J +2 more·2016·Frontiers in Behavioral Neuroscience

Abstract

Social play behavior is a highly rewarding, developmentally important form of social interaction in young mammals. However, its neurobiological underpinnings remain incompletely understood. Previous work has suggested that opioid and endocannabinoid neurotransmission interact in the modulation of social play. Therefore, we combined behavioral, pharmacological, electrophysiological, and genetic approaches to elucidate the role of the endocannabinoid 2-arachidonoylglycerol (2-AG) in social play, and how cannabinoid and opioid neurotransmission interact to control social behavior in adolescent rodents. Systemic administration of the 2-AG hydrolysis inhibitor JZL184 or the opioid receptor agonist morphine increased social play behavior in adolescent rats. These effects were blocked by systemic pretreatment with either CB1 cannabinoid receptor (CB1R) or mu-opioid receptor (MOR) antagonists. The social play-enhancing effects of systemic morphine or JZL184 treatment were also prevented by direct infusion of the CB1R antagonist SR141716 and the MOR antagonist naloxone into the nucleus accumbens core (NAcC). Searching for synaptic correlates of these effects in adolescent NAcC excitatory synapses, we observed that CB1R antagonism blocked the effect of the MOR agonist DAMGO and, conversely, that naloxone reduced the effect of a cannabinoid agonist. These results were recapitulated in mice, and completely abolished in CB1R and MOR knockout mice, suggesting that the functional interaction between CB1R and MOR in the NAcC in the modulation of social behavior is widespread in rodents. The data shed new light on the mechanism by which endocannabinoid lipids and opioid peptides interact to orchestrate rodent socioemotional behaviors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnbeh.2016.00211

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Systemic injection of an endocannabinoid agonist increases play fighting through actions on the CB1 receptor, and the nucleus accumbens and basolateral amygdala are implicated in these effects.

    “Systemic injection of an endocannabinoid agonist was shown to increase play fighting though actions on the CB1 receptor, and the nucleus accumbens (NAc) and basolateral amygdala (BLA) have been implicated in these effects23,24.”

    From Peripubertal stress increases play fighting at adolescence and modulates nucleus accumbens CB1 receptor expression and mitochondrial function in the amygdala (2018) · cites this paper as [23]

    The Results report that systemic JZL184 increased pinning and pouncing in adolescent rats, and that a CB1 receptor antagonist blocked the effect. The Introduction implicates both the nucleus accumbens and basolateral amygdala in endocannabinoid-related social play. But JZL184 is a 2-AG hydrolysis inhibitor, not an injected endocannabinoid agonist. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Intra-BLA and intra-NAc infusions of an endocannabinoid agonist increase play fighting through actions on the CB1 receptor.

    “Given that both, intra-BLA and intra-NAc infusions of an endocannabinoid agonist increase play fighting23,24 through actions on the CB1 receptor23,24,53, we assessed CB1 mRNA levels in these brain regions.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 84 · Cited by 73

Research works printed but not linked: 72

  1. Achterberg E. J. M. van Kerkhof L. W. M. Servadio M. van Swieten M. M. Houwing D. J. Aalderink M.. (2016). Contrasting roles of dopamine and noradrenaline in the motivational properties of social play behavior in rats. Neuropsychopharmacology 41, 858– 868. 10.1038/npp.2015.212 26174597 PMC4707831 · DOI · Paper page
  2. Aliczki M. Varga Z. K. Balogh Z. Haller J. (2014). Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. Psychopharmacology 232, 2157– 2167. 10.1007/s00213-014-3846-1 25547462 · DOI
  3. Befort K. (2015). Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. Front. Pharmacol. 6: 6. 10.3389/fphar.2015.00006 25698968 PMC4318341 · DOI
  4. Berridge K. C. Ho C. Y. Richard J. M. DiFeliceantonio A. G. (2010). The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 1350, 43– 64. 10.1016/j.brainres.2010.04.003 20388498 PMC2913163 · DOI · Paper page
  5. Berridge K. C. Kringelbach M. L. (2015). Pleasure systems in the brain. Neuron 86, 646– 664. 10.1016/j.neuron.2015.02.018 25950633 PMC4425246 · DOI · Paper page
  6. Biscaia M. Fernández B. Higuera-Matas A. Miguéns M. Viveros M. P. García-Lecumberri C.. (2008). Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology 54, 863– 873. 10.1016/j.neuropharm.2008.01.006 18329053 · DOI
  7. Caille S. Parsons L. H. (2003). SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats. Eur. J. Neurosci. 18, 3145– 3149. 10.1111/j.1460-9568.2003.02961.x 14656311 · DOI
  8. Calcagnetti D. J. Schechter M. D. (1992). Place conditioning reveals the rewarding aspect of social interaction in juvenile rats. Physiol. Behav. 51, 667– 672. 10.1016/0031-9384(92)90101-7 1594664 · DOI · Paper page
  9. Campolongo P. Trezza V. (2012). The endocannabinoid system: a key modulator of emotions and cognition. Front. Behav. Neurosci. 6: 73. 10.3389/fnbeh.2012.00073 23133409 PMC3490098 · DOI
  10. Campolongo P. Trezza V. Ratano P. Palmery M. Cuomo V. (2011). Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology 214, 5– 15. 10.1007/s00213-010-1892-x 20556598 PMC3045519 · DOI
  11. Castillo P. E. Younts T. J. Chávez A. E. Hashimotodani Y. (2012). Endocannabinoid signaling and synaptic function. Neuron 76, 70– 81. 10.1016/j.neuron.2012.09.020 23040807 PMC3517813 · DOI
  12. Chaperon F. Soubrié P. Puech A. J. Thiébot M. H. (1998). Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135, 324– 332. 10.1007/s002130050518 9539255 · DOI
  13. Ellgren M. Artmann A. Tkalych O. Gupta A. Hansen H. S. Hansen S. H.. (2008). Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur. Neuropsychopharmacol. 18, 826– 834. 10.1016/j.euroneuro.2008.06.009 18674887 PMC2745315 · DOI
  14. Ellgren M. Spano S. M. Hurd Y. L. (2007). Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 32, 607– 615. 10.1038/sj.npp.1301127 16823391 · DOI
  15. Everitt B. J. Robbins T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481– 1489. 10.1038/nn1579 16251991 · DOI · Paper page
  16. Fattore L. Spano S. Cossu G. Deiana S. Fadda P. Fratta W. (2005). Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology 48, 1097– 1104. 10.1016/j.neuropharm.2005.01.022 15910886 · DOI
  17. Floresco S. B. (2015). The nucleus accumbens: an interface between cognition, emotion, and action. Annu. Rev. Psychol. 66, 25– 52. 10.1146/annurev-psych-010213-115159 25251489 · DOI · Paper page
  18. Goldstein A. Naidu A. (1989). Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36, 265– 272. 2549383
  19. Gunaydin L. A. Deisseroth K. (2014). Dopaminergic Dynamics contributing to social behavior. Cold Spring Harb. Symp. Quant. Biol. 79, 221– 227. 10.1101/sqb.2014.79.024711 25943769 · DOI
  20. Hoffman A. F. Oz M. Caulder T. Lupica C. R. (2003). Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 23, 4815– 4820. 12832502 PMC6741179
  21. Hojo M. Sudo Y. Ando Y. Minami K. Takada M. Matsubara T.. (2008). mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J. Pharmacol. Sci. 108, 308– 319. 10.1254/jphs.08244FP 19008645 · DOI
  22. Hudson B. D. Hébert T. E. Kelly M. E. (2010). Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors. Br. J. Pharmacol. 160, 627– 642. 10.1111/j.1476-5381.2010.00681.x 20590567 PMC2931563 · DOI
  23. Janecka M. Manduca A. Servadio M. Trezza V. Smith R. Mill J.. (2015). Effects of advanced paternal age on trajectories of social behavior in offspring. Genes Brain Behav. 14, 443– 453. 10.1111/gbb.12227 26096767 · DOI
  24. Jordan R. (2003). Social play and autistic spectrum disorders: a perspective on theory, implications and educational approaches. Autism 7, 347– 360. 10.1177/1362361303007004002 14678675 · DOI · Paper page
  25. Jung K. M. Sepers M. Henstridge C. M. Lassalle O. Neuhofer D. Martin H.. (2012). Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 3: 1080. 10.1038/ncomms2045 23011134 PMC3657999 · DOI
  26. Kasanetz F. Deroche-Gamonet V. Berson N. Balado E. Lafourcade M. Manzoni O.. (2010). Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 328, 1709– 1712. 10.1126/science.1187801 20576893 · DOI
  27. Katona I. Freund T. F. (2012). Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 35, 529– 558. 10.1146/annurev-neuro-062111-150420 22524785 PMC4273654 · DOI · Paper page
  28. Lafourcade M. Larrieu T. Mato S. Duffaud A. Sepers M. Matias I.. (2011). Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14, 345– 350. 10.1038/nn.2736 21278728 · DOI
  29. Ledent C. Valverde O. Cossu G. Petitet F. Aubert J. F. Beslot F.. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401– 404. 10.1126/science.283.5400.401 9888857 · DOI
  30. Le Merrer J. Becker J. A. J. Befort K. Kieffer B. (2009). Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379– 1412. 10.1152/physrev.00005.2009 19789384 PMC4482114 · DOI · Paper page
  31. Long J. Z. Nomura D. K. Cravatt B. F. (2009). Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem. Biol. 16, 744– 753. 10.1016/j.chembiol.2009.05.009 19635411 PMC2867454 · DOI
  32. Mackie K. (2005). Cannabinoid receptor homo- and heterodimerization. Life Sci. 77, 1667– 1673. 10.1016/j.lfs.2005.05.011 15978631 · DOI
  33. Manduca A. Morena M. Campolongo P. Servadio M. Palmery M. Trabace L.. (2015). Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats. Eur. Neuropsychopharmacol. 25, 1362– 1374. 10.1016/j.euroneuro.2015.04.005 25914159 · DOI
  34. Manduca A. Servadio M. Damsteegt R. Campolongo P. Vanderschuren L. J. M. J. Trezza V. (2016). Dopaminergic neurotransmission in the nucleus accumbens modulates social play behavior in rats. Neuropsychopharmacology 41, 2215– 2223. 10.1038/npp.2016.22 26860202 PMC4946055 · DOI · Paper page
  35. Mansour A. Hoversten M. T. Taylor L. P. Watson S. J. Akil H. (1995). The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res. 700, 89– 98. 10.1016/0006-8993(95)00928-J 8624732 · DOI
  36. Marco E. M. Rapino C. Caprioli A. Borsini F. Maccarrone M. Laviola G. (2011). Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system. Behav. Brain Res. 220, 140– 145. 10.1016/j.bbr.2011.01.044 21295077 · DOI
  37. Morena M. De Castro V. Gray J. M. Palmery M. Trezza V. Roozendaal B.. (2015). Training-associated emotional arousal shapes endocannabinoid modulation of spatial memory retrieval in rats. J. Neurosci. 35, 13962– 13974. 10.1523/JNEUROSCI.1983-15.2015 26468197 PMC6608184 · DOI
  38. Mulvihill M. M. Nomura D. K. (2013). Therapeutic potential of monoacylglycerol lipase inhibitors. Life Sci. 92, 492– 497. 10.1016/j.lfs.2012.10.025 23142242 PMC3594462 · DOI
  39. Naudon L. Piscitelli F. Giros B. Di Marzo V. Daugé V. (2013). Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat. Neuropharmacology 65, 193– 199. 10.1016/j.neuropharm.2012.10.008 23089638 · DOI
  40. Niesink R. J. M. Van Ree J. M. (1989). Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats. Neuropharmacology 28, 411– 418. 10.1016/0028-3908(89)90038-5 2546087 · DOI · Paper page
  41. Panksepp J. Beatty W. W. (1980). Social deprivation and play in rats. Behav. Neural Biol. 30, 197– 206. 10.1016/S0163-1047(80)91077-8 7447871 · DOI · Paper page
  42. Paxinos G. Watson C. (2007). The Rat Brain in Stereotaxic Coordinates, Vol. 6. San Diego, CA: Elsevier Academic Press.
  43. Pellis S. M. Pasztor T. J. (1999). The developmental onset of a rudimentary form of play fighting in C57 mice. Dev. Psychobiol. 34, 175– 182. 10.1002/(SICI)1098-2302(199904)34:3<175::AID-DEV2>3.0.CO;2-# 10204093 · DOI
  44. Pellis S. Pellis V. (2009). The Playful Brain: Venturing to the Limits of Neuroscience. Oxford: Oneworld Publications.
  45. Pertwee R. G. (2010). Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem. 17, 1360– 1381. 10.2174/092986710790980050 20166927 PMC3013229 · DOI
  46. Pickel V. M. Chan J. Kash T. L. Rodríguez J. J. MacKie K. (2004). Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127, 101– 112. 10.1016/j.neuroscience.2004.05.015 15219673 · DOI
  47. Puente N. Cui Y. Lassalle O. Lafourcade M. Georges F. Venance L.. (2011). Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci. 14, 1542– 1547. 10.1038/nn.2974 22057189 · DOI · Paper page
  48. Robbe D. Alonso G. Duchamp F. Bockaert J. Manzoni O. J. (2001). Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21, 109– 116. 11150326 PMC6762427
  49. Robbe D. Alonso G. Manzoni O. J. (2003). Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann. N.Y. Acad. Sci. 1003, 212– 225. 10.1196/annals.1300.013 14684448 · DOI
  50. Robbe D. Kopf M. Remaury A. Bockaert J. Manzoni O. J. (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 99, 8384– 8388. 10.1073/pnas.122149199 12060781 PMC123076 · DOI
  51. Salio C. Fischer J. Franzoni M. F. Mackie K. Kaneko T. Conrath M. (2001). CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport 12, 3689– 3692. 10.1097/00001756-200112040-00017 11726775 · DOI
  52. Sanchis-Segura C. Cline B. H. Marsicano G. Lutz B. Spanagel R. (2004). Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology 176, 223– 232. 10.1007/s00213-004-1877-8 15083252 · DOI
  53. Schoffelmeer A. N. M. Hogenboom F. Wardeh G. De Vries T. J. (2006). Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology 51, 773– 781. 10.1016/j.neuropharm.2006.05.019 16806307 · DOI
  54. Seillier A. Dominguez Aguilar D. Giuffrida A. (2014). The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Pharmacol. Biochem. Behav. 124, 153– 159. 10.1016/j.pbb.2014.05.022 24911644 PMC4150743 · DOI
  55. Shapira M. Vogel Z. Sarne Y. (2000). Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell. Mol. Neurobiol. 20, 291– 304. 10.1023/A:1007058008477 10789829 PMC11537524 · DOI
  56. Solinas M. Goldberg S. R. Piomelli D. (2008). The endocannabinoid system in brain reward processes. Br. J. Pharmacol. 154, 369– 383. 10.1038/bjp.2008.130 18414385 PMC2442437 · DOI
  57. Solinas M. Panlilio L. V. Antoniou K. Pappas L. A. Goldberg S. R. (2003). The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther. 306, 93– 102. 10.1124/jpet.102.047928 12660305 · DOI
  58. Terranova M. L. Laviola G. (2005). Scoring of social interactions and play in mice during adolescence. Curr. Protoc. Toxicol. Chapter 13:Unit 13.10. 10.1002/0471140856.tx1310s26 23045110 · DOI
  59. Trezza V. Baarendse P. J. J. Vanderschuren L. J. M. J. (2010). The pleasures of play: pharmacological insights into social reward mechanisms. Trends Pharmacol. Sci. 31, 463– 469. 10.1016/j.tips.2010.06.008 20684996 PMC2946511 · DOI · Paper page
  60. Trezza V. Campolongo P. Vanderschuren L. J. M. J. (2011a). Evaluating the rewarding nature of social interactions in laboratory animals. Dev. Cogn. Neurosci. 1, 444– 458. 10.1016/j.dcn.2011.05.007 22436566 PMC6987553 · DOI · Paper page
  61. Trezza V. Damsteegt R. Manduca A. Petrosino S. Van Kerkhof L. W. M. Pasterkamp R. J.. (2012). Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J. Neurosci. 32, 14899– 14908. 10.1523/JNEUROSCI.0114-12.2012 23100412 PMC3496852 · DOI · Paper page
  62. Trezza V. Vanderschuren L. J. M. J. (2008a). Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology 197, 217– 227. 10.1007/s00213-007-1025-3 18058088 · DOI · Paper page
  63. Trezza V. Vanderschuren L. J. M. J. (2008b). Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms. Eur. Neuropsychopharmacol. 18, 519– 530. 10.1016/j.euroneuro.2008.03.001 18434104 PMC2490798 · DOI
  64. Trezza V. Vanderschuren L. J. M. J. (2009). Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. J. Pharmacol. Exp. Ther. 328, 343– 350. 10.1124/jpet.108.141069 18948500 PMC2605777 · DOI
  65. Vanderschuren L. J. M. J. Achterberg E. J. M. Trezza V. (2016). The neurobiology of social play and its rewarding value in rats. Neurosci. Biobehav. Rev. 70, 86– 105. 10.1016/j.neubiorev.2016.07.025 27587003 PMC5074863 · DOI · Paper page
  66. Vanderschuren L. J. M. J. Niesink R. J. M. Spruijt B. M. Van Ree J. M. (1995a). Effects of morphine on different aspects of social play in juvenile rats. Psychopharmacology 117, 225– 231. 10.1007/BF02245191 7753971 · DOI · Paper page
  67. Vanderschuren L. J. M. J. Niesink R. J. M. Van Ree J. M. (1997). The neurobiology of social play behavior in rats. Neurosci. Biobehav. Rev. 21, 309– 326. 10.1016/S0149-7634(96)00020-6 9168267 · DOI · Paper page
  68. Vanderschuren L. J. M. J. Stein E. A. Wiegant V. M. Van Ree J. M. (1995b). Social play alters regional brain opioid receptor binding in juvenile rats. Brain Res. 680, 148– 156. 10.1016/0006-8993(95)00256-P 7663971 · DOI · Paper page
  69. Vanderschuren L. J. M. J. Trezza V. Griffioen-Roose S. Schiepers O. J. G. Van Leeuwen N. De Vries T. J.. (2008). Methylphenidate disrupts social play behavior in adolescent rats. Neuropsychopharmacology 33, 2946– 2956. 10.1038/npp.2008.10 18305462 PMC2580804 · DOI · Paper page
  70. Viveros M. P. Marco E. M. Llorente R. López-Gallardo M. (2007). Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast. 2007: 52908. 10.1155/2007/52908 17641734 PMC1906867 · DOI
  71. Wei D. Lee D. Cox C. D. Karsten C. A. Peñagarikano O. Geschwind D. H.. (2015). Endocannabinoid signaling mediates oxytocin-driven social reward. Proc. Natl. Acad. Sci. U.S.A. 112, 14084– 14089. 10.1073/pnas.1509795112 26504214 PMC4653148 · DOI · Paper page
  72. Wei D. Lee D. Li D. Daglian J. Jung K. M. Piomelli D. (2016). A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice. Psychopharmacology 233, 1911– 1919. 10.1007/s00213-016-4222-0 26873082 PMC5118226 · DOI

Authors
Manduca, A., Lassalle, O., Sepers, M., Campolongo, P., Cuomo, V., Marsicano, G., Kieffer, B., Vanderschuren, L. J. M. J., Trezza, V., & Manzoni, O. J. J.
Affiliations
  • Inserm (FR)
  • Sapienza University of Rome (IT)
  • Université de Bordeaux (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Utrecht University (NL)
  • Roma Tre University (IT)
Corresponding author
  • Trezza, Viviana
  • Manzoni, Olivier J. J.
Venue
Frontiers in Behavioral Neuroscience
Published
2016-11-16
Volume
10
Pages
211-211
ISSN
1662-5153 (ISSN-L)
OpenAlex
W2554580891
Cited by
73
References
84
Citations by year
2026: 1 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 6
FWCI
7.28
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Behavioral Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Iris (Roma Tre University) (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Institut National de la Recherche Agronomique
  • Association Nationale de la Recherche et de la Technologie (Presynaptic-CB1R)
  • National Institute on Drug Abuse
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
social play, endocannabinoid system, opioid system, CB1 receptor, mu-opioid receptor, nucleus accumbens core, 2-arachidonoylglycerol, JZL184, morphine, naloxone, DAMGO, adolescent rats, synaptic transmission, opioid-cannabinoid interaction, social behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review